Nicolo Cabrera, MD, Joseph Cherabie, MD, MSc, and Adriana Rauseo, MD, Assistant Professors of Medicine, and Aaloke Mody, MD, Associate Professor in Medicine, have joined more than a dozen other Washington University School of Medicine Division of Infectious Diseases faculty members as Fellows of the Infectious Diseases Society of America (IDSA). They are among 166 new fellows this year to receive the Fellowship in IDSA (FIDSA) this year.
The 2026 class of fellows includes distinguished clinicians and scientists from across the U.S. and around the world. The FIDSA designation is one of the highest honors in infectious diseases, recognizing individuals whose careers reflect deep curiosity, scientific excellence and a commitment to compassionate care and health equity.
I am honored to be recognized by my peers for my commitment to the field of infectious diseases.
Nicolo Cabrera, MD
Fellows are self-nominated and approved by the IDSA Board of Directors for their sustained impact on research, education, public health and clinical care. Cabrera said he was encouraged by senior WashU Medicine ID colleagues to apply for FIDSA. “I am honored to be recognized by my peers for my commitment to the field of infectious diseases,” Cabrera said. “It’s a pleasure to share this distinction with many of my mentors and teachers.”
Mody is a physician with training in HIV, infectious diseases, implementation science and epidemiologic methods. His clinical research focuses on improving delivery of high-quality, person-centered HIV care and advancing the real-world implementation of public health programs.
Rauseo specializes in clinical infectious diseases with a particular focus on invasive fungal infections and serves as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU), where she contributes to multiple clinical trials.
Cabrera specializes in clinical infectious disease, with a special focus on infectious disease in the setting of transplant, cancer and other forms of immune compromise. He served as the Medical Director of the Ventricular Assist Device Infection Clinic. As faculty from 2021 to 2026, Cabrera attended on multiple services, teaching fellows, residents and students. He has since relocated to his home country of the Philippines, and he said he looks forward to teaching, training and working with medical students, residents and fellows there.
“I intend to practice a broad range of ID including HIV, STIs and viral hepatitis as well as share my expertise in the diagnosis and treatment of infections in transplant recipients, patients with cancer and other patients with various forms of immune compromise,” Cabrera said.
These ID physicians and scientists represent the passion and commitment needed to educate leaders around the globe about current and future health threats.
IDSA President Ronald G. Nahass, MD, MHCM, FIDSA
Cherabie specializes in sexual healthcare with a focus on LGBTQIA+ health, sexually transmitted infections and HIV, all within the lens of medical education. While at WashU Medicine, they served as medical director of the St. Louis STI/HIV Prevention Training Center and co-authored the Washington Manual of Medical Therapeutics chapter on sexually transmitted infections and HIV. Cherabie was a faculty member from 2019 to 2026. He joined Howard Brown Health in Chicago, Illinois as the Senior Medical Director of Clinical Research in April 2026.
In an announcement, IDSA President Ronald G. Nahass, MD, MHCM, FIDSA, noted that the FIDSA designation is awarded to those who have demonstrated leadership within the field of infectious diseases. “These ID physicians and scientists represent the passion and commitment needed to educate leaders around the globe about current and future health threats,” Nahass said.
The Infectious Diseases Society of America is a global community of 13,000 clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks.